Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

967506

	registered interest
	date	04/09/2018
	answering body	Foreign and Commonwealth Office
	answering dept id	16
	answering dept short name	Foreign and Commonwealth Office
	answering dept sort name	Foreign and Commonwealth Office
	hansard heading	Christopher Allen
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assistance they have provided to the family of the British citizen, Christopher Allen, who was killed in South Sudan in August 2017.
	tabling member printed	Baroness Northover
	uin	HL9995
	answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>​US consular services contacted the Foreign and Commonwealth Office for advice regarding Christopher Allen’s death in South Sudan, a dual US/UK national. Consular assistance was provided by the US consular services in Sudan and the USA, following the decision by the family to repatriate Mr Allen to the USA.</p> answering member printed Lord Ahmad of Wimbledon grouped question UIN HL9993 HL9994 question first answered 12/09/2018 15:44:14 answering member 4210 label Biography information for Lord Ahmad of Wimbledon
	tabling member	2539 label Biography information for Baroness Northover

967890

	registered interest
	date	04/09/2018
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	hansard heading	Synthetic Cannabinoids: South West
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, what recent discussions he has had with Devon and Cornwall Police on tackling the availability and use of synthetic cannabinoid substances.
	tabling member constituency	St Austell and Newquay
	tabling member printed	Steve Double
	uin	170368
	answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>We have regular discussions with the National Police Chiefs’ Council on the issue of synthetic cannabinoids and we recognise how dangerous they can be and the devastating impact that they can have on communities, families and the individuals taking them.</p><p>That is why we acted to control these substances as class B drugs under the Misuse of Drugs Act 1971 in 2016, to give the police the powers they need to take action, including making possession illegal and delivering longer sentences for dealers.</p><p>This followed recommendations from the Advisory Council on the Misuse of Drugs that their harms are commensurate with other class B drugs.</p><p>However, we will continue to monitor their impact.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd grouped question UIN 170369 question first answered 12/09/2018 16:04:28 answering member 1561 label Biography information for Mr Nick Hurd
	tabling member	4452 label Biography information for Steve Double

967891

	registered interest
	date	04/09/2018
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	hansard heading	Synthetic Cannabinoids
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, whether his Department plans to reclassify synthetic cannabinoid substances as class A drugs.
	tabling member constituency	St Austell and Newquay
	tabling member printed	Steve Double
	uin	170369
	answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>We have regular discussions with the National Police Chiefs’ Council on the issue of synthetic cannabinoids and we recognise how dangerous they can be and the devastating impact that they can have on communities, families and the individuals taking them.</p><p>That is why we acted to control these substances as class B drugs under the Misuse of Drugs Act 1971 in 2016, to give the police the powers they need to take action, including making possession illegal and delivering longer sentences for dealers.</p><p>This followed recommendations from the Advisory Council on the Misuse of Drugs that their harms are commensurate with other class B drugs.</p><p>However, we will continue to monitor their impact.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd grouped question UIN 170368 question first answered 12/09/2018 16:04:28 answering member 1561 label Biography information for Mr Nick Hurd
	tabling member	4452 label Biography information for Steve Double

967806

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the total value of rebates to be paid under the Pharmaceutical Price Regulation Scheme 2014.
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	uin	170343
	answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>The Department has received £2,328 million from members of the Pharmaceutical Price Regulation Scheme (PPRS), as of Q1 2018, in respect of PPRS payments made under the 2014 scheme. The estimated United Kingdom income from PPRS payments in 2018/19 is £470 million. Published aggregate information on sales reports and payments made under the scheme on a quarterly basis can be found on the Government’s website at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information" target="_blank">https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information</a></p><p> </p><p>The Department administers the scheme on behalf of all UK nations and PPRS payments that companies make under the scheme in respect of the UK are allocated to each of the four countries on an agreed basis each year. The Department ensures that all the income it receives from PPRS payments in England is reinvested in the National Health Service for patients’ benefit. The Department includes the expected PPRS payments in setting the NHS England allocations in advance of each year. NHS England is responsible for allocating the overall budget between clinical commissioning groups, specialised commissioning etc.</p><p> </p><p>Following normal Government accounting rules, there is no separately identified or ring-fenced funding stream associated with the PPRS payment. The Government is committed to improving access to clinically and cost-effective medicines including innovative new medicines and to optimise patient outcomes from these medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 170344 170345 question first answered 12/09/2018 16:32:57 answering member 4067 label Biography information for Steve Brine
	tabling member	4382 label Biography information for Daniel Zeichner

967807

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what information his Department holds on how money raised from rebates paid under the Pharmaceutical Price Regulation Scheme 2014 has been used; and if he will make a statement.
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	uin	170344
	answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>The Department has received £2,328 million from members of the Pharmaceutical Price Regulation Scheme (PPRS), as of Q1 2018, in respect of PPRS payments made under the 2014 scheme. The estimated United Kingdom income from PPRS payments in 2018/19 is £470 million. Published aggregate information on sales reports and payments made under the scheme on a quarterly basis can be found on the Government’s website at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information" target="_blank">https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information</a></p><p> </p><p>The Department administers the scheme on behalf of all UK nations and PPRS payments that companies make under the scheme in respect of the UK are allocated to each of the four countries on an agreed basis each year. The Department ensures that all the income it receives from PPRS payments in England is reinvested in the National Health Service for patients’ benefit. The Department includes the expected PPRS payments in setting the NHS England allocations in advance of each year. NHS England is responsible for allocating the overall budget between clinical commissioning groups, specialised commissioning etc.</p><p> </p><p>Following normal Government accounting rules, there is no separately identified or ring-fenced funding stream associated with the PPRS payment. The Government is committed to improving access to clinically and cost-effective medicines including innovative new medicines and to optimise patient outcomes from these medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 170343 170345 question first answered 12/09/2018 16:32:58 answering member 4067 label Biography information for Steve Brine
	tabling member	4382 label Biography information for Daniel Zeichner

967808

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reasons rebates paid by manufacturers under the Pharmaceutical Price Regulation Scheme 2014 are not ring-fenced for the use of medicines; and if he will make a statement.
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	uin	170345
	answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>The Department has received £2,328 million from members of the Pharmaceutical Price Regulation Scheme (PPRS), as of Q1 2018, in respect of PPRS payments made under the 2014 scheme. The estimated United Kingdom income from PPRS payments in 2018/19 is £470 million. Published aggregate information on sales reports and payments made under the scheme on a quarterly basis can be found on the Government’s website at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information" target="_blank">https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information</a></p><p> </p><p>The Department administers the scheme on behalf of all UK nations and PPRS payments that companies make under the scheme in respect of the UK are allocated to each of the four countries on an agreed basis each year. The Department ensures that all the income it receives from PPRS payments in England is reinvested in the National Health Service for patients’ benefit. The Department includes the expected PPRS payments in setting the NHS England allocations in advance of each year. NHS England is responsible for allocating the overall budget between clinical commissioning groups, specialised commissioning etc.</p><p> </p><p>Following normal Government accounting rules, there is no separately identified or ring-fenced funding stream associated with the PPRS payment. The Government is committed to improving access to clinically and cost-effective medicines including innovative new medicines and to optimise patient outcomes from these medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 170343 170344 question first answered 12/09/2018 16:32:58 answering member 4067 label Biography information for Steve Brine
	tabling member	4382 label Biography information for Daniel Zeichner

967892

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Alcoholic Drinks and Drugs: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people have been in contact with drug and alcohol services since 2009-10; what assessment he has made of the reasons for changes in the number of people making contact during that time period; and what steps his Department is taking to ensure that people are able to make contact with drug and alcohol services.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	170329
	answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>Public Health England (PHE) publishes national statistics on alcohol and drug treatment.</p><p>The numbers of people in contact with alcohol and drug treatment services since 2009-10 are shown in the following table.</p><p>Numbers of people in contact with alcohol and drug treatment services since 2009-10</p><table><tbody><tr><td><p>Year</p></td><td><p>Number</p></td></tr><tr><td><p>2009-10</p></td><td><p>311,667</p></td></tr><tr><td><p>2010-11</p></td><td><p>309,000</p></td></tr><tr><td><p>2011-12</p></td><td><p>299,565</p></td></tr><tr><td><p>2012-13</p></td><td><p>297,105</p></td></tr><tr><td><p>2013-14</p></td><td><p>301,944</p></td></tr><tr><td><p>2014-15</p></td><td><p>295,224</p></td></tr><tr><td><p>2015-16</p></td><td><p>288,843</p></td></tr><tr><td><p>2016-17</p></td><td><p>279,793</p></td></tr></tbody></table><p>Source: Substance misuse treatment for adults: statistics 2016 to 2017 <a href="https://www.gov.uk/government/statistics/substance-misuse-and-treatment-in-adults-statistics-2016-to-2017" target="_blank">https://www.gov.uk/government/statistics/substance-misuse-and-treatment-in-adults-statistics-2016-to-2017</a></p><p>In 2016-17, nearly 280,000 people received treatment for alcohol and drugs, a decrease of 3% and the largest drop seen over the last six years. This decrease is largely due to the reduction in people starting treatment for alcohol problems only. The numbers of people getting treatment for alcohol has fallen by 12% from a peak of 91,651 in 2013-14.</p><p>PHE is assessing the reasons for the fall in alcohol treatment numbers through work with local authorities to look closely at treatment numbers and reasons for changes in the number of people in treatment. Based on this, PHE will be providing advice to local authorities.</p><p>Data on numbers of people who have discontinued treatment is not available in the format requested.</p><p>PHE is continuing to support local authorities to commission effective, accessible treatment services to meet local need. It does this by providing data, including online management reporting and a new Public Health Dashboard, as well as guidance and other tailored support for local authorities.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 170330 question first answered 12/09/2018 15:55:00 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

967893

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Alcoholic Drinks and Drugs: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people have discontinued drug and alcohol treatment within (a) three months and (b) six months of starting such treatment in each of the last seven financial years; and what plans his Department has to reduce such discontinuation rates.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	170330
	answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>Public Health England (PHE) publishes national statistics on alcohol and drug treatment.</p><p>The numbers of people in contact with alcohol and drug treatment services since 2009-10 are shown in the following table.</p><p>Numbers of people in contact with alcohol and drug treatment services since 2009-10</p><table><tbody><tr><td><p>Year</p></td><td><p>Number</p></td></tr><tr><td><p>2009-10</p></td><td><p>311,667</p></td></tr><tr><td><p>2010-11</p></td><td><p>309,000</p></td></tr><tr><td><p>2011-12</p></td><td><p>299,565</p></td></tr><tr><td><p>2012-13</p></td><td><p>297,105</p></td></tr><tr><td><p>2013-14</p></td><td><p>301,944</p></td></tr><tr><td><p>2014-15</p></td><td><p>295,224</p></td></tr><tr><td><p>2015-16</p></td><td><p>288,843</p></td></tr><tr><td><p>2016-17</p></td><td><p>279,793</p></td></tr></tbody></table><p>Source: Substance misuse treatment for adults: statistics 2016 to 2017 <a href="https://www.gov.uk/government/statistics/substance-misuse-and-treatment-in-adults-statistics-2016-to-2017" target="_blank">https://www.gov.uk/government/statistics/substance-misuse-and-treatment-in-adults-statistics-2016-to-2017</a></p><p>In 2016-17, nearly 280,000 people received treatment for alcohol and drugs, a decrease of 3% and the largest drop seen over the last six years. This decrease is largely due to the reduction in people starting treatment for alcohol problems only. The numbers of people getting treatment for alcohol has fallen by 12% from a peak of 91,651 in 2013-14.</p><p>PHE is assessing the reasons for the fall in alcohol treatment numbers through work with local authorities to look closely at treatment numbers and reasons for changes in the number of people in treatment. Based on this, PHE will be providing advice to local authorities.</p><p>Data on numbers of people who have discontinued treatment is not available in the format requested.</p><p>PHE is continuing to support local authorities to commission effective, accessible treatment services to meet local need. It does this by providing data, including online management reporting and a new Public Health Dashboard, as well as guidance and other tailored support for local authorities.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 170329 question first answered 12/09/2018 15:55:00 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

967882

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Alcoholic Drinks and Drugs: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure equality of access to (a) alcohol and (b) drug treatments.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	170323
	answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>The Department and Public Health England (PHE) are working with other Government departments to help prevent young people, including those from deprived backgrounds, from developing alcohol and drug problems. This includes supporting investment in programmes which have a positive impact on young people, giving them the confidence, resilience and risk management skills to resist drug use. Examples of this include:</p><p>- funding Mentor UK’s Alcohol and Drug Education and Prevention Information Service which provides practical advice and tools based on the best international evidence, including briefing sheets for teachers; and</p><p>- running Rise Above, an online resilience building resource, aimed at 11- to 16-year-olds, which provides resources to help young people develop skills to make positive choices for their health, including avoiding drug use.</p><p>Local authorities are responsible for assessing their local need for alcohol and drug treatment and commissioning a range of accessible services to meet these needs.</p><p>PHE works with local authorities to support them in this vital work, by providing them with data, guidance and other bespoke support to help them tackle health inequalities.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 170324 170325 question first answered 12/09/2018 15:59:43 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

967883

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Alcoholic Drinks and Drugs: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to tackle dependence on (a) illicit drugs and (b) alcohol among people from deprived backgrounds; and if he will make a statement.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	170324
	answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>The Department and Public Health England (PHE) are working with other Government departments to help prevent young people, including those from deprived backgrounds, from developing alcohol and drug problems. This includes supporting investment in programmes which have a positive impact on young people, giving them the confidence, resilience and risk management skills to resist drug use. Examples of this include:</p><p>- funding Mentor UK’s Alcohol and Drug Education and Prevention Information Service which provides practical advice and tools based on the best international evidence, including briefing sheets for teachers; and</p><p>- running Rise Above, an online resilience building resource, aimed at 11- to 16-year-olds, which provides resources to help young people develop skills to make positive choices for their health, including avoiding drug use.</p><p>Local authorities are responsible for assessing their local need for alcohol and drug treatment and commissioning a range of accessible services to meet these needs.</p><p>PHE works with local authorities to support them in this vital work, by providing them with data, guidance and other bespoke support to help them tackle health inequalities.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 170323 170325 question first answered 12/09/2018 15:59:43 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth